Medical Condition News

RSS

Genotype may help identify patients at increased risk for sickle cell disease-related complications

Researchers have found a genotype that could help identify sickle cell disease (SCD) patients at greatest risk of common, yet severe, complications of SCD.

7 Nov 2017

Study reveals link between circulating tumor cells and relapse in late-stage melanoma patients

A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid biopsy as a potential predictor of patients at high risk for disease progression. CTCs, tumor cells shed into the bloodstream or lymphatic system, can lead to additional tumor growth and/or metastasis to distant sites.

7 Nov 2017

SBP researchers identify new protective function for brain protein genetically linked to Alzheimer's

Researchers at Sanford Burnham Prebys Medical Discovery Institute have identified a new protective function for a brain protein genetically linked to Alzheimer's. The findings, published in the Journal of Experimental Medicine, could inform novel treatment strategies.

7 Nov 2017

New study finds enhanced impact of drug combination for FAP patients

People with an inherited syndrome called familial adenomatous polyposis (FAP) have a 100% lifetime risk of developing colorectal cancer if they do not seek appropriate medical care.

7 Nov 2017

Study finds link between increased brain glucose levels and Alzheimer's

A new study published yesterday in Alzheimer's & Dementia: the Journal of the Alzheimer's Association, found a link for the first time between abnormalities in the mechanism of glucose breakdown in the brain and the severity of tangles and amyloid plaques in the brain, as well as the commencement of visible symptoms of Alzheimer's disease.

7 Nov 2017

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

A popular drug commonly used to treat Alzheimer's disease has shown promise in laboratory and clinical trials for treating patients with sickle cell disease (SCD).

7 Nov 2017

Mental stress and anticipation of pain may trigger painful sickle cell episodes

Mental stress and the anticipation of pain may cause blood vessels to narrow and trigger episodes of severe pain (vaso-occlusive crisis, or VOC) in sickle cell disease (SCD).

7 Nov 2017

High protein diet may have deleterious long-term impact on kidney health

High protein diets may lead to long-term kidney damage among those suffering from chronic kidney disease, according to research led by nephrologist Kamyar Kalantar-Zadeh, MD, MPH, PhD, of the University of California, Irvine.

7 Nov 2017

Researchers identify mechanisms through which H. pylori bacteria cause gastric cancer

Gastric cancer is one of the five most fatal types of cancer. According to the statistics of the World Health Organization, about 750,000 patients die each year after developing the disease. The main cause is thought to be the bacterium Helicobacter pylori (H. pylori).

7 Nov 2017

Study shows promise and potential risk in reversing hearing loss using inner ear stem cells

Want to restore hearing by injecting stem cells into the inner ear? Well, that can be a double-edged sword.

7 Nov 2017

Study shows lupus support line as valuable resource to help patients cope with disease

A free telephone support and education program for people with lupus is a valuable resource to help them cope with the disease, according to a study at Hospital for Special Surgery in New York City.

7 Nov 2017

FDA approves first targeted cancer treatment based on basket study

The US Food and Drug Administration has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD).

7 Nov 2017

Immune system plays surprising role in the aftermath of heart attacks, study finds

A study led by Kevin King, a bioengineer and physician at the University of California San Diego, has found that the immune system plays a surprising role in the aftermath of heart attacks. The research could lead to new therapeutic strategies for heart disease.

7 Nov 2017

FDA grants approval to first treatment for rare blood cancer

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.

7 Nov 2017

Common antidepressants may not work for depressed patients with chronic kidney disease

Scientists are finding more evidence that commonly prescribed antidepressants aren't effective in people battling both depression and a chronic medical disease, raising a critical question of whether doctors should enact widespread changes in how they treat millions of depressed Americans.

7 Nov 2017

Researchers identify new neuroprotective factor that holds potential to help people with glaucoma

A research team led by scientists at the Krembil Research Institute in Toronto has identified a new neuroprotective factor that has the potential to help people suffering from the common blinding disease glaucoma.

7 Nov 2017

Fat hormone associated with NASH may be effective target for therapeutic intervention

The rising obesity epidemic has brought with it an army of maladies. One, in particular, is threatening to outpace many of the disorders that accompany obesity, in terms of occurrence and severity: nonalcoholic fatty liver disease.

7 Nov 2017

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

Italian researchers have demonstrated a better way of determining the aggressiveness of tumors in patients with advanced non-small cell lung cancer (NSCLC).

7 Nov 2017

FDA approves new drug Zelboraf for Erdheim-Chester disease

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

6 Nov 2017

NIH awards grant to test whether anti-inflammatory diet can reduce Alzheimer's disease risk

The National Institutes of Health has awarded Albert Einstein College of Medicine nutrition scientist Yasmin Mossavar-Rahmani, Ph.D., R.D., a five-year, $4 million grant to test whether a diet rich in foods with anti-inflammatory properties can reduce cognitive decline and Alzheimer's disease risk.

6 Nov 2017

Medical Condition News

Genotype may help identify patients at increased risk for sickle cell disease-related complications

Study reveals link between circulating tumor cells and relapse in late-stage melanoma patients

SBP researchers identify new protective function for brain protein genetically linked to Alzheimer's

New study finds enhanced impact of drug combination for FAP patients

Study finds link between increased brain glucose levels and Alzheimer's

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

Mental stress and anticipation of pain may trigger painful sickle cell episodes

High protein diet may have deleterious long-term impact on kidney health

Researchers identify mechanisms through which H. pylori bacteria cause gastric cancer

Study shows promise and potential risk in reversing hearing loss using inner ear stem cells

Study shows lupus support line as valuable resource to help patients cope with disease

FDA approves first targeted cancer treatment based on basket study

Immune system plays surprising role in the aftermath of heart attacks, study finds

FDA grants approval to first treatment for rare blood cancer

Common antidepressants may not work for depressed patients with chronic kidney disease

Researchers identify new neuroprotective factor that holds potential to help people with glaucoma

Fat hormone associated with NASH may be effective target for therapeutic intervention

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

FDA approves new drug Zelboraf for Erdheim-Chester disease

NIH awards grant to test whether anti-inflammatory diet can reduce Alzheimer's disease risk

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News